Virotherapy News and Research

RSS
Virotherapy is treatment using a virus that has been changed in the laboratory to find and destroy cancer cells without harming healthy cells. It is a type of targeted therapy. Also called oncolytic virotherapy, oncolytic virus therapy, and viral therapy.
Genetically modified herpes virus can be used in the fight against cancer

Genetically modified herpes virus can be used in the fight against cancer

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Study opens up prospects for using virotherapy to treat central nervous system tumors

Study opens up prospects for using virotherapy to treat central nervous system tumors

Peto's paradox offers new insights into cancer risk across mammals

Peto's paradox offers new insights into cancer risk across mammals

Review highlights oncolytic viruses with remarkable ability to destroy cancer cells

Review highlights oncolytic viruses with remarkable ability to destroy cancer cells

Personalized vaccine can provide effective immunization against cancer

Personalized vaccine can provide effective immunization against cancer

Novel platform uses modified virus to combat pancreatic cancer

Novel platform uses modified virus to combat pancreatic cancer

Scientists solve 3D structure of vaccinia virus RNA polymerase

Scientists solve 3D structure of vaccinia virus RNA polymerase

Children's of Alabama using cold sore virus to fight pediatric brain cancer

Children's of Alabama using cold sore virus to fight pediatric brain cancer

PCRF awards £1.2M grants for new research projects tackling pancreatic cancer

PCRF awards £1.2M grants for new research projects tackling pancreatic cancer

Study reveals how Seneca Valley Virus interacts with tumor receptors

Study reveals how Seneca Valley Virus interacts with tumor receptors

Themis, Max-Planck-Innovation sign license agreement to develop and commercialize oncolytic virotherapies

Themis, Max-Planck-Innovation sign license agreement to develop and commercialize oncolytic virotherapies

Researchers develop cancer vaccine platform to improve efficacy of oncolytic enveloped viruses

Researchers develop cancer vaccine platform to improve efficacy of oncolytic enveloped viruses

New clinical trial to evaluate virotherapy and immunotherapy combination for ovarian, colorectal cancers

New clinical trial to evaluate virotherapy and immunotherapy combination for ovarian, colorectal cancers

Mayo discovery could enable development of personalized ovarian, brain cancer treatments

Mayo discovery could enable development of personalized ovarian, brain cancer treatments

Pioneering study could be a step closer to finding the most effective way to treat cancer

Pioneering study could be a step closer to finding the most effective way to treat cancer

Researchers reveal promising method for delivering cancer virotherapy

Researchers reveal promising method for delivering cancer virotherapy

Scientists receive critical funding to study treatments for three deadly cancers

Scientists receive critical funding to study treatments for three deadly cancers

Scientists develop potential new therapy for targeting skin cancer metastases in the brain

Scientists develop potential new therapy for targeting skin cancer metastases in the brain

Combination of immunotherapies effective against mouse model of rhabdomyosarcoma

Combination of immunotherapies effective against mouse model of rhabdomyosarcoma